FRAGILE: FRench Attitude reGistry in case of ICD LEad replacement.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
08 03 2021
Historique:
received: 07 04 2020
accepted: 09 09 2020
pubmed: 2 12 2020
medline: 10 8 2021
entrez: 1 12 2020
Statut: ppublish

Résumé

FRench Attitude reGistry in case of ICD LEad replacement (FRAGILE) registry was set-up to describe the attitude in different French institutions in case of implantable cardioverter-defibrillator (ICD) lead replacement, extraction, or abandonment and to compare outcomes in both groups. Prospective observational study comparing two attitudes in case of ICD lead replacement, extraction, or abandonment. Primary endpoint describes the attitude in different French centres, collect parameters that may influence the decision. Secondary endpoint compares early and mid-term (2 years) complications in both groups.Between April 2013 and April 2017, 552 patients were included in 32 centres. 434 (78.6%) were male, mean patient's age was 60.3 ± 14.4 years. In 56.9% of the cases, the decision was to explant the lead. Patients in the extraction group were younger than in the abandonment group (56.7 ± 14.5 vs. 65 ± 12.7 P < 0.0001) and less likely to have comorbidities (46.5% vs. 58.3% of the patients P = 0.022). The mean lead dwelling time was significantly longer in the abandonment group as compared with the extraction group (7.6 ± 3.9 vs. 5.2 ± 3.1 years, P < 0.0001). There was no statistical difference between both groups concerning early and 2 years complications. In this registry, the strategy in case of non-infected ICD lead replacement was mainly influenced by patient's age and comorbidities and lead dwelling time. No difference was observed in outcomes in both strategies.

Identifiants

pubmed: 33257986
pii: 6012930
doi: 10.1093/europace/euaa290
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

389-394

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Christine Alonso (C)

CMC Ambroise Paré, 25-27 bd Victor Hugo, 92200 Neuilly-sur-Seine, France.

Christelle Marquie (C)

CHRU Lille, France.

Pascal Defaye (P)

CHU Michallon Grenoble, France.

Nicolas Clementy (N)

CHU Trousseau Tours, France.

Pierre Mondoly (P)

CHU Rangueil Toulouse, France.

Nicolas Sadoul (N)

CHU Brabois Nancy, France.

Serge Boveda (S)

Clinique Pasteur Toulouse, France.

Françoise Hidden-Lucet (F)

GH Pitié-Salpétrière Paris, France.

Antoine Dompnier (A)

CH Région Annecienne, France.

Antoine Da Costa (A)

CHU Nord Saint-Etienne, France.

Eloi Marijon (E)

HEGP Paris, France.

Christophe Leclercq (C)

CHU Pontchaillou Rennes, France.

Guillaume Caudron (G)

GH Sud Réunion, France.

Olivier Piot (O)

Centre Cardiologique du Nord Saint-Denis, France.

Jean-Claude Deharo (JC)

CHU La Timone Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH